C79.62
C79.62 — Secondary malignant neoplasm of left ovary
Billable / specific codeICD-10-CMleft
C79.62 is a billable, specific ICD-10-CM code for secondary malignant neoplasm of left ovary. It is valid for submission on a claim.
Risk adjustment
C79.62 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C79.62 is named in 38 Medicare coverage policies — 38 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A52986Billing and Coding: Biomarkers for Oncology
- A53101Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
- A54188Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®
Related codes at this level
Codes that share C79.6. If C79.62 is not quite right, the correct code is usually one of these.
Questions about C79.62
- Is C79.62 a billable ICD-10-CM code?
- Yes. C79.62 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C79.62 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).